Innoviva
INVA
#5515
Rank
$1.54 B
Marketcap
$20.97
Share price
0.53%
Change (1 day)
12.80%
Change (1 year)

Earnings for Innoviva (INVA)

Earnings in 2026 (TTM): $0.60 Billion USD

According to Innoviva's latest financial reports the company's current earnings are $0.42 Billion USD. In 2025 the company made an earning of $0.32 Billion USD, an increase over its 2024 earnings that were of $37.38 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innoviva from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $0.60 B83.57%
2025 $0.32 B774.24%
2024 $37.38 M-80.74%
2023 $0.19 B-32.36%
2022 $0.28 B-35.56%
2021 $0.44 B25.7%
2020 $0.35 B52.11%
2019 $0.23 B10.77%
2018 $0.21 B56.59%
2017 $0.13 B125.53%
2016 $59.53 M-417.36%
2015 -$18.76 Million-74.49%
2014 -$73.53 Million-25.19%
2013 -$98.29 Million430.06%
2012 -$18.55 Million-83.92%
2011 -$0.12 Billion39.82%
2010 -$82.5 Million2.84%
2009 -$80.22 Million-8.62%
2008 -$87.79 Million-47.92%
2007 -$0.17 Billion-5.92%
2006 -$0.18 Billion19.8%
2005 -$0.15 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-$0.23 Billion-138.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-$18.16 Million-103.03%๐Ÿ‡บ๐Ÿ‡ธ USA